
Athena Security uses advanced concealed weapons detection systems to deliver a unified, AI-driven entryway solution for hospitals, K–12 schools, casinos, places of worship, government buildings, and commercial facilities across the U.S. The Apollo 500 enables seamless walk-through screening to detect weapons in real time, giving operators more actionable data points than traditional systems for faster, more confident decisions. Athena’s AI-powered X-ray leverages iPad technology to modernize screening and improve threat detection.
Athena’s Hospital Visitor Management System integrates with EPIC to connect identity, access, and screening data. Innovations include the Ambulance Bay WDS for stretcher screening and secondary screening for bags and lower extremities to reduce human error. Designed with compliance in mind, Athena aligns with California AB 2975, which mandates weapons detection screening at key hospital entrances by 2027 to improve safety and reduce workplace violence.
DHS-aligned workflows ensure testing, controls, and compliance, while telepresence and AR alert glasses provide real-time support. All systems connect in one platform for centralized monitoring and enterprise reporting.
Learn more
You know that you could be testing more to catch bugs earlier, but QA testing can take a lot of time, effort and resources to do it right. MuukTest can get growing engineering teams up to 95% coverage of end-to-end tests in just 3 months.
Our QA experts create, manage, maintain, and update E2E tests on the MuukTest Platform for your web, API, and mobile apps at record speed. We begin exploratory and negative tests after achieving 100% regression coverage within 8 weeks to uncover bugs and increase coverage. The time you spend on development is reduced by managing your testing frameworks, scripts, libraries and maintenance.
We also proactively identify flaky tests and false test results to ensure the accuracy of your tests. Early and frequent testing allows you to detect errors in the early stages your development lifecycle. This reduces the burden of technical debt later on.
Learn more
Qritive
Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.
Learn more
The Galen Platform
Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.
Learn more